0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2026
Published Date: 2026-04-29
|
Report Code: QYRE-Auto-25M18710
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
BUY CHAPTERS

Global Antifungal and Ringworm Treatment Drugs Market Research Report 2026

Code: QYRE-Auto-25M18710
Report
2026-04-29
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antifungal and Ringworm Treatment Drugs Market Size

The global Antifungal and Ringworm Treatment Drugs market was valued at US$ 3710 million in 2025 and is anticipated to reach US$ 4876 million by 2032, at a CAGR of 4.0% from 2026 to 2032.

Antifungal and Ringworm Treatment Drugs Market

Antifungal and Ringworm Treatment Drugs Market

Fungal tinea drugs, also known as fungal drugs for lichen diseases, are drugs used to treat skin tinea diseases caused by fungal infections. Fungal infections usually cause symptoms such as erythema, desquamation, itching, and cracking on the skin. Common diseases include athlete's foot, tinea versicolor, tinea corporis, tinea cruris, and tinea manuum. Fungal infections may be caused by different types of fungi. Antifungal drugs can inhibit or kill these fungi and help treat and relieve symptoms. Currently, commonly used topical antifungal drugs in clinical practice can be divided into imidazoles, allylamines, and other antifungal drugs. Imidazole antifungal drugs include clotrimazole, econazole, miconazole, ketoconazole, etc. Allylamine antifungal drugs include naftifine, terbinafine, and butenafine. Other antifungal drugs include amorolfine, ciclopirox olamine, liranapthate, etc.
There are various types of fungal tinea drugs, including topical drugs and oral drugs. Topical drugs include antifungal creams, sprays, lotions, patches, etc., which are usually used for local treatment of fungal infections of the skin. Oral drugs are mainly used to treat extensive or stubborn fungal infections, such as itraconazole and fluconazole, which have strong systemic therapeutic effects. With the segmentation of treatment needs, some new drug forms, such as long-acting sprays and topical application formulations, have gradually gained market favor and met the treatment needs of different patients.
With the advancement of science and technology, the research and development of fungal tinea drugs around the world has gradually developed towards innovation and efficient treatment. The new generation of antifungal drugs can not only improve the treatment effect, but also optimize the side effects. For example, some new drugs can reduce the risk of liver damage and solve the problem of side effects that may be caused by traditional drugs during long-term use. In addition, the course of treatment and the way of use of drugs are also gradually improving. Many new drugs use more convenient dosage forms and shorter treatment cycles, which are more attractive in the market.
The global market demand for fungal tinea drugs varies in different regions. The markets in developed countries and regions are relatively mature, with higher drug prices and a higher degree of standardized treatment. In developing countries, however, due to the limitations of economic level and medical resources, low-priced generic drugs and basic treatment methods dominate the market. In these regions, despite the higher rates of fungal infections, the popularity and use of drugs are affected. Therefore, global pharmaceutical companies need to consider the differences in demand in different regions when making global layouts and adjust their pricing and market strategies.
This report delivers a comprehensive overview of the global Antifungal and Ringworm Treatment Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antifungal and Ringworm Treatment Drugs. The Antifungal and Ringworm Treatment Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antifungal and Ringworm Treatment Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antifungal and Ringworm Treatment Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Antifungal and Ringworm Treatment Drugs Market Report

Report Metric Details
Report Name Antifungal and Ringworm Treatment Drugs Market
Accounted market size in 2025 US$ 3710 million
Forecasted market size in 2032 US$ 4876 million
CAGR 4.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • External Drug
  • Oral Drug
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Bausch Health, Bayer, Kaken Pharmaceutical, Gufic Biosciences, Galderma, Perrigo, Padagis, GSK, Novartis, Shandong Jingwei Pharmaceutical, Jiangsu Zhiyuan Pharmaceutical, Sandoz, Ultratech India, Teva Pharmaceuticals, Hubei Hengan Fulin, Chengdu Beite Pharmaceuticals, Shanghai Modern Hasen (Shangqiu), Tianjin Lisheng, Shandong Luoxin, Harbin Sanlian, Hainan Kangzhi, Guilin Huaxin, Shandong Qilu, Jiangsu Yunyang Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Antifungal and Ringworm Treatment Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Antifungal and Ringworm Treatment Drugs Market growing?

Ans: The Antifungal and Ringworm Treatment Drugs Market witnessing a CAGR of 4.0% during the forecast period 2026-2032.

What is the Antifungal and Ringworm Treatment Drugs Market size in 2032?

Ans: The Antifungal and Ringworm Treatment Drugs Market size in 2032 will be US$ 4876 million.

Who are the main players in the Antifungal and Ringworm Treatment Drugs Market report?

Ans: The main players in the Antifungal and Ringworm Treatment Drugs Market are Johnson & Johnson, Bausch Health, Bayer, Kaken Pharmaceutical, Gufic Biosciences, Galderma, Perrigo, Padagis, GSK, Novartis, Shandong Jingwei Pharmaceutical, Jiangsu Zhiyuan Pharmaceutical, Sandoz, Ultratech India, Teva Pharmaceuticals, Hubei Hengan Fulin, Chengdu Beite Pharmaceuticals, Shanghai Modern Hasen (Shangqiu), Tianjin Lisheng, Shandong Luoxin, Harbin Sanlian, Hainan Kangzhi, Guilin Huaxin, Shandong Qilu, Jiangsu Yunyang Group

What are the Application segmentation covered in the Antifungal and Ringworm Treatment Drugs Market report?

Ans: The Applications covered in the Antifungal and Ringworm Treatment Drugs Market report are Hospital Pharmacy, Retail Pharmacy, Online

What are the Type segmentation covered in the Antifungal and Ringworm Treatment Drugs Market report?

Ans: The Types covered in the Antifungal and Ringworm Treatment Drugs Market report are External Drug, Oral Drug

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 External Drug
1.2.3 Oral Drug
1.3 Market by Application
1.3.1 Global Antifungal and Ringworm Treatment Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antifungal and Ringworm Treatment Drugs Market Perspective (2021–2032)
2.2 Global Antifungal and Ringworm Treatment Drugs Growth Trends by Region
2.2.1 Global Antifungal and Ringworm Treatment Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Antifungal and Ringworm Treatment Drugs Historic Market Size by Region (2021–2026)
2.2.3 Antifungal and Ringworm Treatment Drugs Forecasted Market Size by Region (2027–2032)
2.3 Antifungal and Ringworm Treatment Drugs Market Dynamics
2.3.1 Antifungal and Ringworm Treatment Drugs Industry Trends
2.3.2 Antifungal and Ringworm Treatment Drugs Market Drivers
2.3.3 Antifungal and Ringworm Treatment Drugs Market Challenges
2.3.4 Antifungal and Ringworm Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antifungal and Ringworm Treatment Drugs Players by Revenue
3.1.1 Global Top Antifungal and Ringworm Treatment Drugs Players by Revenue (2021–2026)
3.1.2 Global Antifungal and Ringworm Treatment Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Antifungal and Ringworm Treatment Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Antifungal and Ringworm Treatment Drugs Revenue
3.4 Global Antifungal and Ringworm Treatment Drugs Market Concentration Ratio
3.4.1 Global Antifungal and Ringworm Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antifungal and Ringworm Treatment Drugs Revenue in 2025
3.5 Global Key Players of Antifungal and Ringworm Treatment Drugs Head Offices and Areas Served
3.6 Global Key Players of Antifungal and Ringworm Treatment Drugs, Products and Applications
3.7 Global Key Players of Antifungal and Ringworm Treatment Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Antifungal and Ringworm Treatment Drugs Breakdown Data by Type
4.1 Global Antifungal and Ringworm Treatment Drugs Historic Market Size by Type (2021–2026)
4.2 Global Antifungal and Ringworm Treatment Drugs Forecasted Market Size by Type (2027–2032)
5 Antifungal and Ringworm Treatment Drugs Breakdown Data by Application
5.1 Global Antifungal and Ringworm Treatment Drugs Historic Market Size by Application (2021–2026)
5.2 Global Antifungal and Ringworm Treatment Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Antifungal and Ringworm Treatment Drugs Market Size (2021–2032)
6.2 North America Antifungal and Ringworm Treatment Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Antifungal and Ringworm Treatment Drugs Market Size by Country (2021–2026)
6.4 North America Antifungal and Ringworm Treatment Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antifungal and Ringworm Treatment Drugs Market Size (2021–2032)
7.2 Europe Antifungal and Ringworm Treatment Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Antifungal and Ringworm Treatment Drugs Market Size by Country (2021–2026)
7.4 Europe Antifungal and Ringworm Treatment Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size (2021–2032)
8.2 Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Antifungal and Ringworm Treatment Drugs Market Size (2021–2032)
9.2 Latin America Antifungal and Ringworm Treatment Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Antifungal and Ringworm Treatment Drugs Market Size by Country (2021–2026)
9.4 Latin America Antifungal and Ringworm Treatment Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size (2021–2032)
10.2 Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Antifungal and Ringworm Treatment Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.1.5 Johnson & Johnson Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Antifungal and Ringworm Treatment Drugs Introduction
11.2.4 Bausch Health Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.2.5 Bausch Health Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Antifungal and Ringworm Treatment Drugs Introduction
11.3.4 Bayer Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.3.5 Bayer Recent Development
11.4 Kaken Pharmaceutical
11.4.1 Kaken Pharmaceutical Company Details
11.4.2 Kaken Pharmaceutical Business Overview
11.4.3 Kaken Pharmaceutical Antifungal and Ringworm Treatment Drugs Introduction
11.4.4 Kaken Pharmaceutical Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.4.5 Kaken Pharmaceutical Recent Development
11.5 Gufic Biosciences
11.5.1 Gufic Biosciences Company Details
11.5.2 Gufic Biosciences Business Overview
11.5.3 Gufic Biosciences Antifungal and Ringworm Treatment Drugs Introduction
11.5.4 Gufic Biosciences Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.5.5 Gufic Biosciences Recent Development
11.6 Galderma
11.6.1 Galderma Company Details
11.6.2 Galderma Business Overview
11.6.3 Galderma Antifungal and Ringworm Treatment Drugs Introduction
11.6.4 Galderma Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.6.5 Galderma Recent Development
11.7 Perrigo
11.7.1 Perrigo Company Details
11.7.2 Perrigo Business Overview
11.7.3 Perrigo Antifungal and Ringworm Treatment Drugs Introduction
11.7.4 Perrigo Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.7.5 Perrigo Recent Development
11.8 Padagis
11.8.1 Padagis Company Details
11.8.2 Padagis Business Overview
11.8.3 Padagis Antifungal and Ringworm Treatment Drugs Introduction
11.8.4 Padagis Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.8.5 Padagis Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Antifungal and Ringworm Treatment Drugs Introduction
11.9.4 GSK Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.9.5 GSK Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Antifungal and Ringworm Treatment Drugs Introduction
11.10.4 Novartis Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.10.5 Novartis Recent Development
11.11 Shandong Jingwei Pharmaceutical
11.11.1 Shandong Jingwei Pharmaceutical Company Details
11.11.2 Shandong Jingwei Pharmaceutical Business Overview
11.11.3 Shandong Jingwei Pharmaceutical Antifungal and Ringworm Treatment Drugs Introduction
11.11.4 Shandong Jingwei Pharmaceutical Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.11.5 Shandong Jingwei Pharmaceutical Recent Development
11.12 Jiangsu Zhiyuan Pharmaceutical
11.12.1 Jiangsu Zhiyuan Pharmaceutical Company Details
11.12.2 Jiangsu Zhiyuan Pharmaceutical Business Overview
11.12.3 Jiangsu Zhiyuan Pharmaceutical Antifungal and Ringworm Treatment Drugs Introduction
11.12.4 Jiangsu Zhiyuan Pharmaceutical Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.12.5 Jiangsu Zhiyuan Pharmaceutical Recent Development
11.13 Sandoz
11.13.1 Sandoz Company Details
11.13.2 Sandoz Business Overview
11.13.3 Sandoz Antifungal and Ringworm Treatment Drugs Introduction
11.13.4 Sandoz Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.13.5 Sandoz Recent Development
11.14 Ultratech India
11.14.1 Ultratech India Company Details
11.14.2 Ultratech India Business Overview
11.14.3 Ultratech India Antifungal and Ringworm Treatment Drugs Introduction
11.14.4 Ultratech India Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.14.5 Ultratech India Recent Development
11.15 Teva Pharmaceuticals
11.15.1 Teva Pharmaceuticals Company Details
11.15.2 Teva Pharmaceuticals Business Overview
11.15.3 Teva Pharmaceuticals Antifungal and Ringworm Treatment Drugs Introduction
11.15.4 Teva Pharmaceuticals Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.15.5 Teva Pharmaceuticals Recent Development
11.16 Hubei Hengan Fulin
11.16.1 Hubei Hengan Fulin Company Details
11.16.2 Hubei Hengan Fulin Business Overview
11.16.3 Hubei Hengan Fulin Antifungal and Ringworm Treatment Drugs Introduction
11.16.4 Hubei Hengan Fulin Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.16.5 Hubei Hengan Fulin Recent Development
11.17 Chengdu Beite Pharmaceuticals
11.17.1 Chengdu Beite Pharmaceuticals Company Details
11.17.2 Chengdu Beite Pharmaceuticals Business Overview
11.17.3 Chengdu Beite Pharmaceuticals Antifungal and Ringworm Treatment Drugs Introduction
11.17.4 Chengdu Beite Pharmaceuticals Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.17.5 Chengdu Beite Pharmaceuticals Recent Development
11.18 Shanghai Modern Hasen (Shangqiu)
11.18.1 Shanghai Modern Hasen (Shangqiu) Company Details
11.18.2 Shanghai Modern Hasen (Shangqiu) Business Overview
11.18.3 Shanghai Modern Hasen (Shangqiu) Antifungal and Ringworm Treatment Drugs Introduction
11.18.4 Shanghai Modern Hasen (Shangqiu) Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.18.5 Shanghai Modern Hasen (Shangqiu) Recent Development
11.19 Tianjin Lisheng
11.19.1 Tianjin Lisheng Company Details
11.19.2 Tianjin Lisheng Business Overview
11.19.3 Tianjin Lisheng Antifungal and Ringworm Treatment Drugs Introduction
11.19.4 Tianjin Lisheng Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.19.5 Tianjin Lisheng Recent Development
11.20 Shandong Luoxin
11.20.1 Shandong Luoxin Company Details
11.20.2 Shandong Luoxin Business Overview
11.20.3 Shandong Luoxin Antifungal and Ringworm Treatment Drugs Introduction
11.20.4 Shandong Luoxin Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.20.5 Shandong Luoxin Recent Development
11.21 Harbin Sanlian
11.21.1 Harbin Sanlian Company Details
11.21.2 Harbin Sanlian Business Overview
11.21.3 Harbin Sanlian Antifungal and Ringworm Treatment Drugs Introduction
11.21.4 Harbin Sanlian Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.21.5 Harbin Sanlian Recent Development
11.22 Hainan Kangzhi
11.22.1 Hainan Kangzhi Company Details
11.22.2 Hainan Kangzhi Business Overview
11.22.3 Hainan Kangzhi Antifungal and Ringworm Treatment Drugs Introduction
11.22.4 Hainan Kangzhi Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.22.5 Hainan Kangzhi Recent Development
11.23 Guilin Huaxin
11.23.1 Guilin Huaxin Company Details
11.23.2 Guilin Huaxin Business Overview
11.23.3 Guilin Huaxin Antifungal and Ringworm Treatment Drugs Introduction
11.23.4 Guilin Huaxin Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.23.5 Guilin Huaxin Recent Development
11.24 Shandong Qilu
11.24.1 Shandong Qilu Company Details
11.24.2 Shandong Qilu Business Overview
11.24.3 Shandong Qilu Antifungal and Ringworm Treatment Drugs Introduction
11.24.4 Shandong Qilu Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.24.5 Shandong Qilu Recent Development
11.25 Jiangsu Yunyang Group
11.25.1 Jiangsu Yunyang Group Company Details
11.25.2 Jiangsu Yunyang Group Business Overview
11.25.3 Jiangsu Yunyang Group Antifungal and Ringworm Treatment Drugs Introduction
11.25.4 Jiangsu Yunyang Group Revenue in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
11.25.5 Jiangsu Yunyang Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of External Drug
 Table 3. Key Players of Oral Drug
 Table 4. Global Antifungal and Ringworm Treatment Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Antifungal and Ringworm Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Antifungal and Ringworm Treatment Drugs Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Antifungal and Ringworm Treatment Drugs Market Share by Region (2021–2026)
 Table 8. Global Antifungal and Ringworm Treatment Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Antifungal and Ringworm Treatment Drugs Market Share by Region (2027–2032)
 Table 10. Antifungal and Ringworm Treatment Drugs Market Trends
 Table 11. Antifungal and Ringworm Treatment Drugs Market Drivers
 Table 12. Antifungal and Ringworm Treatment Drugs Market Challenges
 Table 13. Antifungal and Ringworm Treatment Drugs Market Restraints
 Table 14. Global Antifungal and Ringworm Treatment Drugs Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Antifungal and Ringworm Treatment Drugs Market Share by Players (2021–2026)
 Table 16. Global Top Antifungal and Ringworm Treatment Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antifungal and Ringworm Treatment Drugs Revenue, 2025
 Table 17. Ranking of Global Top Antifungal and Ringworm Treatment Drugs Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Antifungal and Ringworm Treatment Drugs Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Antifungal and Ringworm Treatment Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Antifungal and Ringworm Treatment Drugs, Products and Applications
 Table 21. Global Key Players of Antifungal and Ringworm Treatment Drugs, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Antifungal and Ringworm Treatment Drugs Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Antifungal and Ringworm Treatment Drugs Revenue Market Share by Type (2021–2026)
 Table 25. Global Antifungal and Ringworm Treatment Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Antifungal and Ringworm Treatment Drugs Revenue Market Share by Type (2027–2032)
 Table 27. Global Antifungal and Ringworm Treatment Drugs Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Antifungal and Ringworm Treatment Drugs Revenue Market Share by Application (2021–2026)
 Table 29. Global Antifungal and Ringworm Treatment Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Antifungal and Ringworm Treatment Drugs Revenue Market Share by Application (2027–2032)
 Table 31. North America Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size by Country (US$ Million), 2027–2032
 Table 46. Johnson & Johnson Company Details
 Table 47. Johnson & Johnson Business Overview
 Table 48. Johnson & Johnson Antifungal and Ringworm Treatment Drugs Product
 Table 49. Johnson & Johnson Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 50. Johnson & Johnson Recent Development
 Table 51. Bausch Health Company Details
 Table 52. Bausch Health Business Overview
 Table 53. Bausch Health Antifungal and Ringworm Treatment Drugs Product
 Table 54. Bausch Health Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 55. Bausch Health Recent Development
 Table 56. Bayer Company Details
 Table 57. Bayer Business Overview
 Table 58. Bayer Antifungal and Ringworm Treatment Drugs Product
 Table 59. Bayer Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 60. Bayer Recent Development
 Table 61. Kaken Pharmaceutical Company Details
 Table 62. Kaken Pharmaceutical Business Overview
 Table 63. Kaken Pharmaceutical Antifungal and Ringworm Treatment Drugs Product
 Table 64. Kaken Pharmaceutical Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 65. Kaken Pharmaceutical Recent Development
 Table 66. Gufic Biosciences Company Details
 Table 67. Gufic Biosciences Business Overview
 Table 68. Gufic Biosciences Antifungal and Ringworm Treatment Drugs Product
 Table 69. Gufic Biosciences Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 70. Gufic Biosciences Recent Development
 Table 71. Galderma Company Details
 Table 72. Galderma Business Overview
 Table 73. Galderma Antifungal and Ringworm Treatment Drugs Product
 Table 74. Galderma Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 75. Galderma Recent Development
 Table 76. Perrigo Company Details
 Table 77. Perrigo Business Overview
 Table 78. Perrigo Antifungal and Ringworm Treatment Drugs Product
 Table 79. Perrigo Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 80. Perrigo Recent Development
 Table 81. Padagis Company Details
 Table 82. Padagis Business Overview
 Table 83. Padagis Antifungal and Ringworm Treatment Drugs Product
 Table 84. Padagis Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 85. Padagis Recent Development
 Table 86. GSK Company Details
 Table 87. GSK Business Overview
 Table 88. GSK Antifungal and Ringworm Treatment Drugs Product
 Table 89. GSK Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 90. GSK Recent Development
 Table 91. Novartis Company Details
 Table 92. Novartis Business Overview
 Table 93. Novartis Antifungal and Ringworm Treatment Drugs Product
 Table 94. Novartis Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 95. Novartis Recent Development
 Table 96. Shandong Jingwei Pharmaceutical Company Details
 Table 97. Shandong Jingwei Pharmaceutical Business Overview
 Table 98. Shandong Jingwei Pharmaceutical Antifungal and Ringworm Treatment Drugs Product
 Table 99. Shandong Jingwei Pharmaceutical Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 100. Shandong Jingwei Pharmaceutical Recent Development
 Table 101. Jiangsu Zhiyuan Pharmaceutical Company Details
 Table 102. Jiangsu Zhiyuan Pharmaceutical Business Overview
 Table 103. Jiangsu Zhiyuan Pharmaceutical Antifungal and Ringworm Treatment Drugs Product
 Table 104. Jiangsu Zhiyuan Pharmaceutical Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 105. Jiangsu Zhiyuan Pharmaceutical Recent Development
 Table 106. Sandoz Company Details
 Table 107. Sandoz Business Overview
 Table 108. Sandoz Antifungal and Ringworm Treatment Drugs Product
 Table 109. Sandoz Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 110. Sandoz Recent Development
 Table 111. Ultratech India Company Details
 Table 112. Ultratech India Business Overview
 Table 113. Ultratech India Antifungal and Ringworm Treatment Drugs Product
 Table 114. Ultratech India Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 115. Ultratech India Recent Development
 Table 116. Teva Pharmaceuticals Company Details
 Table 117. Teva Pharmaceuticals Business Overview
 Table 118. Teva Pharmaceuticals Antifungal and Ringworm Treatment Drugs Product
 Table 119. Teva Pharmaceuticals Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 120. Teva Pharmaceuticals Recent Development
 Table 121. Hubei Hengan Fulin Company Details
 Table 122. Hubei Hengan Fulin Business Overview
 Table 123. Hubei Hengan Fulin Antifungal and Ringworm Treatment Drugs Product
 Table 124. Hubei Hengan Fulin Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 125. Hubei Hengan Fulin Recent Development
 Table 126. Chengdu Beite Pharmaceuticals Company Details
 Table 127. Chengdu Beite Pharmaceuticals Business Overview
 Table 128. Chengdu Beite Pharmaceuticals Antifungal and Ringworm Treatment Drugs Product
 Table 129. Chengdu Beite Pharmaceuticals Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 130. Chengdu Beite Pharmaceuticals Recent Development
 Table 131. Shanghai Modern Hasen (Shangqiu) Company Details
 Table 132. Shanghai Modern Hasen (Shangqiu) Business Overview
 Table 133. Shanghai Modern Hasen (Shangqiu) Antifungal and Ringworm Treatment Drugs Product
 Table 134. Shanghai Modern Hasen (Shangqiu) Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 135. Shanghai Modern Hasen (Shangqiu) Recent Development
 Table 136. Tianjin Lisheng Company Details
 Table 137. Tianjin Lisheng Business Overview
 Table 138. Tianjin Lisheng Antifungal and Ringworm Treatment Drugs Product
 Table 139. Tianjin Lisheng Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 140. Tianjin Lisheng Recent Development
 Table 141. Shandong Luoxin Company Details
 Table 142. Shandong Luoxin Business Overview
 Table 143. Shandong Luoxin Antifungal and Ringworm Treatment Drugs Product
 Table 144. Shandong Luoxin Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 145. Shandong Luoxin Recent Development
 Table 146. Harbin Sanlian Company Details
 Table 147. Harbin Sanlian Business Overview
 Table 148. Harbin Sanlian Antifungal and Ringworm Treatment Drugs Product
 Table 149. Harbin Sanlian Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 150. Harbin Sanlian Recent Development
 Table 151. Hainan Kangzhi Company Details
 Table 152. Hainan Kangzhi Business Overview
 Table 153. Hainan Kangzhi Antifungal and Ringworm Treatment Drugs Product
 Table 154. Hainan Kangzhi Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 155. Hainan Kangzhi Recent Development
 Table 156. Guilin Huaxin Company Details
 Table 157. Guilin Huaxin Business Overview
 Table 158. Guilin Huaxin Antifungal and Ringworm Treatment Drugs Product
 Table 159. Guilin Huaxin Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 160. Guilin Huaxin Recent Development
 Table 161. Shandong Qilu Company Details
 Table 162. Shandong Qilu Business Overview
 Table 163. Shandong Qilu Antifungal and Ringworm Treatment Drugs Product
 Table 164. Shandong Qilu Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 165. Shandong Qilu Recent Development
 Table 166. Jiangsu Yunyang Group Company Details
 Table 167. Jiangsu Yunyang Group Business Overview
 Table 168. Jiangsu Yunyang Group Antifungal and Ringworm Treatment Drugs Product
 Table 169. Jiangsu Yunyang Group Revenue in Antifungal and Ringworm Treatment Drugs Business (US$ Million), 2021–2026
 Table 170. Jiangsu Yunyang Group Recent Development
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. Authors List of This Report


List of Figures
 Figure 1. Antifungal and Ringworm Treatment Drugs Picture
 Figure 2. Global Antifungal and Ringworm Treatment Drugs Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Antifungal and Ringworm Treatment Drugs Market Share by Type: 2025 vs 2032
 Figure 4. External Drug Features
 Figure 5. Oral Drug Features
 Figure 6. Global Antifungal and Ringworm Treatment Drugs Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Antifungal and Ringworm Treatment Drugs Market Share by Application: 2025 vs 2032
 Figure 8. Hospital Pharmacy Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Online Case Studies
 Figure 11. Antifungal and Ringworm Treatment Drugs Report Years Considered
 Figure 12. Global Antifungal and Ringworm Treatment Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Antifungal and Ringworm Treatment Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Antifungal and Ringworm Treatment Drugs Market Share by Region: 2025 vs 2032
 Figure 15. Global Antifungal and Ringworm Treatment Drugs Market Share by Players in 2025
 Figure 16. Global Antifungal and Ringworm Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Antifungal and Ringworm Treatment Drugs Revenue in 2025
 Figure 18. North America Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Antifungal and Ringworm Treatment Drugs Market Share by Country (2021–2032)
 Figure 20. United States Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Antifungal and Ringworm Treatment Drugs Market Share by Country (2021–2032)
 Figure 24. Germany Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Antifungal and Ringworm Treatment Drugs Market Share by Region (2021–2032)
 Figure 32. China Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Antifungal and Ringworm Treatment Drugs Market Share by Country (2021–2032)
 Figure 40. Mexico Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Antifungal and Ringworm Treatment Drugs Market Share by Country (2021–2032)
 Figure 44. Israel Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Antifungal and Ringworm Treatment Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Johnson & Johnson Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 48. Bausch Health Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 49. Bayer Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 50. Kaken Pharmaceutical Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 51. Gufic Biosciences Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 52. Galderma Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 53. Perrigo Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 54. Padagis Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 55. GSK Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 56. Novartis Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 57. Shandong Jingwei Pharmaceutical Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 58. Jiangsu Zhiyuan Pharmaceutical Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 59. Sandoz Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 60. Ultratech India Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 62. Hubei Hengan Fulin Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 63. Chengdu Beite Pharmaceuticals Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 64. Shanghai Modern Hasen (Shangqiu) Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 65. Tianjin Lisheng Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 66. Shandong Luoxin Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 67. Harbin Sanlian Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 68. Hainan Kangzhi Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 69. Guilin Huaxin Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 70. Shandong Qilu Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 71. Jiangsu Yunyang Group Revenue Growth Rate in Antifungal and Ringworm Treatment Drugs Business (2021–2026)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture